Skip Navigation

A Phase I Study of SEA-BCMA in Patients with Relapsed or Refractory Multiple Myeloma

Brief Summary

Type:
Multiple Myeloma

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT03582033

Study #:
STUDY00142718

Start Date:
Nov 07, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03582033

View Complete Trial Details & Eligibility at ClinicalTrials.gov